Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer
Huang, Yanqi1,2; Liu, Zaiyi1; He, Lan1,3; Chen, Xin4; Pan, Dan1; Ma, Zelan1,2; Liang, Cuishan1,2; Tian, Jie5; Liang, Changhong1
刊名RADIOLOGY
2016-12-01
卷号281期号:3页码:947-957
DOI10.1148/radiol.2016152234
文献子类Article
英文摘要Purpose: To develop a radiomics signature to estimate disease-free survival (DFS) in patients with early-stage (stage I-II) non-small cell lung cancer (NSCLC) and assess its incremental value to the traditional staging system and clinicalpathologic risk factors for individual DFS estimation.
WOS关键词CLINICAL-PRACTICE GUIDELINES ; TUMOR HETEROGENEITY ; BLADDER-CANCER ; FOLLOW-UP ; MODEL ; CHEMOTHERAPY ; DIAGNOSIS ; VALIDATION ; REGRESSION ; PHENOTYPES
WOS研究方向Radiology, Nuclear Medicine & Medical Imaging
语种英语
WOS记录号WOS:000393201500029
资助机构National Natural Scientific Foundation of China(81271569 ; 81271654 ; U1301258)
内容类型期刊论文
源URL[http://ir.ia.ac.cn/handle/173211/14366]  
专题自动化研究所_中国科学院分子影像重点实验室
作者单位1.Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Radiol, 106 Zhongshan Er Rd, Guangzhou 510080, Guangdong, Peoples R China
2.Southern Med Univ, Grad Coll, Guangzhou, Guangdong, Peoples R China
3.South China Univ Technol, Sch Med, Guangzhou, Guangdong, Peoples R China
4.Guangzhou Med Univ, Dept Radiol, Affiliated Guangzhou Peoples Hosp 1, Guangzhou, Guangdong, Peoples R China
5.Chinese Acad Sci, Key Lab Mol Imaging, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Huang, Yanqi,Liu, Zaiyi,He, Lan,et al. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer[J]. RADIOLOGY,2016,281(3):947-957.
APA Huang, Yanqi.,Liu, Zaiyi.,He, Lan.,Chen, Xin.,Pan, Dan.,...&Liang, Changhong.(2016).Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.RADIOLOGY,281(3),947-957.
MLA Huang, Yanqi,et al."Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer".RADIOLOGY 281.3(2016):947-957.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace